How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,981 results for

Cholesterol Education Resources

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

261. Management of Dyslipidaemia

. Applicability of the Guidelines and Resource Implications: This guideline was developed taking into account our local health resources. Blood chemistry for lipid profiles, liver and renal function tests can be done in all government health facilities. Almost all the medications recommended (except for the PCSK9 inhibitors) are approved for use in Malaysia and available in public hospitals as generics. This guideline aims to educate health care professional on strategies to optimize existing resources (...) . Atherosclerosis affects the entire vascular tree. However, evidence for a causal link is strongest for CVD (heart disease and strokes). • Strategies for assessing CV risk that is most applicable to our local population. • Evidence based management of dyslipidaemia, utilising existing healthcare resources wherever possible. Process: This CPG has been drawn up by a committee appointed by the National Heart Association of Malaysia, Ministry of Health and the Academy of Medicine. It comprises cardiologists

2017 Ministry of Health, Malaysia

262. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

Rosuvastatin; LDL-C = low-density lipoprotein cholesterol; Lp-PLA2 = lipoprotein-associ- ated phospholipase A2; MACE = major cardiovascular events; MESA = Multi-Ethnic Study of Atherosclerosis; MetS = metabolic syndrome; MI = myocardial infarc- tion; MRFIT = Multiple Risk Factor Intervention Trial; NCEP = National Cholesterol Education Program; NHLBI = National Heart, Lung, and Blood Institute; PCOS = polycystic ovary syndrome; PCSK9 = propro- tein convertase subtilisin/kexin type 9; Post CABG = CPG (...) of Clinical Endocrinologists (AACE) Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Dyslipidemia and Prevention of Atherosclerosis (6 [EL 4; NE]), and complements the AACE Diabetes Mellitus Comprehensive Care Plan CPG (7 [EL 4; NE]). The landmark National Cholesterol Education Program (NCEP) guidelines (8 [EL 4; NE]) serve as the backbone of these lipid recommendations. This CPG is unique in that it supports the use of apoli- poprotein (apo) B level and/or LDL particle

2017 American Association of Clinical Endocrinologists

263. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association

adult CHD (ACHD) admissions to an intensive care unit, abnormal thyroid, creatinine, and bilirubin tests were highly pre- dictive of both intensive care unit and hospital mortal- ity. 19 Furthermore, comorbidities can be costly. A recent study demonstrated renal insufficiency as a primary driver of high resource use for ACHD hospitalizations, which account for only 10% of the admissions but make up one third of the total hospital charges. 20 The impact of noncardiac comorbidities on both car- diac (...) and it is imperative that centers allocate resourc- es to provide comprehensive care to this population. To further decrease morbidity and mortality in patients with CHD, understanding and managing noncardiac complications becomes as important as knowing their cardiac history. This review covers some of the organ systems most frequently affected in the adult with CHD (Figure 1). RENAL Prevalence Renal dysfunction has long been described in cyanotic CHD but is common among adults with all forms of CHD. 26,27

Full Text available with Trip Pro

2017 American Heart Association

264. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Treatment and Control e71 12.1. Adherence Strategies for Treatment of Hypertension e71 12.1.1. Antihypertensive Medication Adherence Strategies e71 12.1.2. Strategies to Promote Lifestyle Modification e71 12.1.3. Improving Quality of Care for Resource-Constrained Populations e72 12.2. Structured, Team-Based Care Interventions for Hypertension Control e73 12.3. Health Information Technology–Based Strategies to Promote Hypertension Control e73 12.3.1. EHR and Patient Registries e73 12.3.2. Telehealth (...) Council recommended that the NHLBI focus specifically on reviewing the highest-quality evidence and partner with other organizations to develop recommendations. Accordingly, the ACC and AHA collaborated with the NHLBI and stakeholder and professional organizations to complete and publish 4 guidelines (on assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk, management of blood cholesterol in adults, and management of overweight and obesity in adults) to make them

2017 American Heart Association

265. American Heart Association Principles on the Accessibility and Affordability of Drugs and Biologics: A Presidential Advisory From the American Heart Association

, , , and September 2011 , , , , , and September 2008 February 1998 December 12, 2017 Vol 136, Issue 24 Article Information Metrics Download : 250 © 2017 American Heart Association, Inc. PubMed Originally published November 9, 2017 Keywords Subjects Title Title Title Title Circulation AHA Journals Journal Information Subjects Features Resources & Education For Authors & Reviewers National Center 7373 Greenville Ave. Dallas, TX 75231 Customer Service 1-800-AHA-USA-1 1-800-242-8721 ABOUT US OUR SITES TAKE ACTION (...) in and testing of precision medicine diagnostics and treatments will bring additional costs in the short term. Although there is a lack of consensus as to the importance or magnitude of the contribution of any factor to this pricing trend, there is agreement that no one healthcare stakeholder, nor the system as a whole, can afford it. Recognizing this fact, dialogue has begun about assessing value as a way to match payment and resource allocation decisions to a product’s alignment with patient, societal

Full Text available with Trip Pro

2017 American Heart Association

266. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association

, and other government agencies, brings together in a single document the most up- to-date statistics related to heart disease, stroke, and the factors in the AHA’s Life’s Simple 7 (Figure 1 ), which include core health behaviors (smoking, physical activity [PA], diet, and weight) and health factors (cholesterol, blood pressure [BP], and glucose control) that contribute to cardiovascular health. The Statistical Update represents a critical resource for the lay public, policy makers, media professionals (...) Behaviors 3. Smoking/Tobacco Use . . . . . . . . . . . . . . e183 4. Physical Inactivity . . . . . . . . . . . . . . . . e196 5. Nutrition . . . . . . . . . . . . . . . . . . . . . e214 6. Overweight and Obesity . . . . . . . . . . . . . e240 Health Factors and Other Risk Factors 7. Family History and Genetics . . . . . . . . . . . e263 8. High Blood Cholesterol and Other Lipids . . . . . e270 9. High Blood Pressure . . . . . . . . . . . . . . . e280 10. Diabetes Mellitus

Full Text available with Trip Pro

2017 American Heart Association

267. Methodological Standards for Meta-Analyses and Qualitative Systematic Reviews of Cardiac Prevention and Treatment Studies: A Scientific Statement From the American Heart Association

that there is a distribution of true effect sizes among the studies in the analysis (ie, effect sizes may vary from study to study.) Effect sizes may vary on the basis of many factors, including the age, education, or sex of participants or the intensity of the intervention.Forest plot: a visual summary of a meta-analysis in which the effect size estimate, confidence interval, and weight of each study are presented along with the pooled summary effect size estimate and confidence interval.Cumulative meta-analysis: Data

2017 American Heart Association

268. Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association

of these studies that should be deliberated. Insights Provided by Animal Models There has been a long history of using animal models to provide insight into mechanisms of human atherosclerosis. A large number of animal studies have contributed to the notion that lowering plasma cholesterol concentrations is an effective mode of reducing atherosclerosis, which has led to therapeutic approaches for reducing plasma cholesterol concentration to effectively reduce atherosclerosis-related diseases in humans (...) ) transgene expression in hypercholesterolemic mice in reducing atherosclerosis. , These observations contributed to the development of high-density lipoprotein (HDL) infusion therapies in humans. Similarly, mouse studies provided the first evidence that PCSK9 (proprotein convertase subtilisin/kexin type 9) increases plasma low-density lipoprotein (LDL) cholesterol concentrations by reducing expression of LDL receptors and showed that PCSK9 was secreted by the liver, which implied that circulating PCSK9

Full Text available with Trip Pro

2017 American Heart Association

269. Defining Optimal Brain Health in Adults

brain health in adults based on inclusion of factors that could be measured, monitored, and modified. From these practical considerations, we identified 7 metrics to define optimal brain health in adults that originated from AHA’s Life’s Simple 7: 4 ideal health behaviors (nonsmoking, physical activity at goal levels, healthy diet consistent with current guideline levels, and body mass index <25 kg/m 2 ) and 3 ideal health factors (untreated blood pressure <120/<80 mm Hg, untreated total cholesterol (...) to be highest in South Korea, western European countries, and some emerging economies. Anticipated gains in longevity will occur in older age groups, particularly among women. By 2030, it is estimated there will be a >50% probability that women in some of the aforementioned regions will break the 90-year survival barrier. These gains may be explained by improvements in social status, education, and childhood and adolescent nutrition; expanded primary and secondary health care; a rapid scale-up of new

Full Text available with Trip Pro

2017 American Heart Association

270. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non?ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update 4. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 5. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline (...) that a separate outpatient CAD measure set will likely address smoking cessation advice/counseling). The writing committee also recognizes the importance of the American Medical Association/Physician Consortium for Performance Improvement Tobacco Use: Screening and Cessation Intervention measure that already exists. QM-1 Inpatient LDL Cholesterol Assessment This measure is being retired to be concordant with the new lipid guidelines that no longer recommend LDL measurements to target statin prescription

2017 American Heart Association

271. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association (PubMed)

Development in Young Adults), in which 26 of the 27 incident heart failure cases that occurred in individuals <50 years of age were among black participants. Although disparities in heart failure persist in middle-aged and older adults (mean age, 62 years) in MESA (Multi-Ethnic Study of Atherosclerosis; HR, 1.81; 95% CI, 1.07–3.07 in African Americans versus whites), statistical adjustment for established risk factors (ie, age, sex, diabetes mellitus, hypertension, cholesterol, smoking status, and left (...) to or lower than those of non-Hispanic whites. For example, the prevalence of elevated total cholesterol (≥200 mg/dL) was 37.0% in non-Hispanic white males versus 32.6% in non-Hispanic blacks in NHANES 2011 to 2014. Comparable percentages of elevated total cholesterol among women were 43.4% among non-Hispanic whites and 36.1% in non-Hispanic blacks. High-density lipoprotein (HDL) cholesterol is known to be higher in African Americans, and in recent estimates from NHANES, those patterns hold

Full Text available with Trip Pro

2017 American Heart Association

272. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

mass index, systolic blood pressure, hypertension treatment, diabetes mellitus, current smoking, ratio of total to high-density lipoprotein cholesterol, valvular heart disease, and prevalent myocardial infarction (Framingham Heart Score). Other data further support the potential utility of natriuretic peptides to predict the long-term development of HF. Older adults with initially low biomarker concentrations that demonstrated a rise in both NT-proBNP >25% and cardiac troponin T (cTnT) >50% over (...) -guided prognostication may aid resource allocation. Biomarker-assisted prognostication also facilitates patient-provider communication and the shared decision-making process. Clear communication about prognosis helps to establish patient-caregiver expectations about the short- and long-term goals of care. Finally, biomarker-guided risk prediction can aid patient selection for clinical trials by identifying patients at highest risk of clinical events. Natriuretic Peptides Values of BNP and NT-proBNP

Full Text available with Trip Pro

2017 American Heart Association

273. Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association

Resources & Education For Authors & Reviewers National Center 7373 Greenville Ave. Dallas, TX 75231 Customer Service 1-800-AHA-USA-1 1-800-242-8721 ABOUT US OUR SITES TAKE ACTION ONLINE COMMUNITIES Follow Us: © American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is qualified 501(c)(3) tax-exempt organization. *Red Dress ™ DHHS, Go Red ™; National Wear Red Day ® is registered trademark. (...) mortality has declined, the devastating impact of chronic heart disease and comorbidities on quality of life and healthcare resources continues unabated. Future strides, extending those made in recent decades, will require continued research into mechanisms underlying disease prevention, pathogenesis, progression, and therapeutic intervention. However, severe financial constraints currently jeopardize these efforts. To chart a path for the future, this report analyzes the challenges and opportunities we

2017 American Heart Association

274. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary

focus specifically on reviewing the highest-quality evidence and partner with other organizations to develop recommendations. Accordingly, the ACC and AHA collaborated with the NHLBI and stakeholder and professional organizations to complete and publish 4 guidelines (on assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk, management of blood cholesterol in adults, and management of overweight and obesity in adults) to make them available to the widest possible (...) evidence and partner with other organizations to develop recommendations. Accordingly, the ACC and AHA collaborated with the NHLBI and stakeholder and professional organizations to complete and publish 4 guidelines (on assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk, management of blood cholesterol in adults, and management of overweight and obesity in adults) to make them available to the widest possible constituency. In 2014, the ACC and AHA in partnership

2017 American Heart Association

275. Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions

. Estrogen decreases levels of low-density lipoprotein cholesterol, increases levels of high-density lipoprotein cholesterol, and has a vasodilator effect. Despite these observations, data from randomized clinical trials show a lack of benefit, or even a harmful effect, of hormone therapy on risk of coronary heart disease in postmenopausal women. Several potential factors, including timing of initiation of hormone therapy with respect to menopause, older age, and presence of atheroma, have been proposed (...) Angeles); Maureen G. Phipps, MD, MPH (Brown University, Providence, Rhode Island); Michael Silverstein, MD, MPH (Boston University, Boston, Massachusetts); Melissa A. Simon, MD, MPH (Northwestern University, Evanston, Illinois); Chien-Wen Tseng, MD, MPH, MSEE (University of Hawaii, Honolulu, and Pacific Health Research and Education Institute, Honolulu, Hawaii). References: 1. Gartlehner G, Patel S, Viswanathan M, et al. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions

2017 U.S. Preventive Services Task Force

276. Management of Type 2 Diabetes Mellitus

, social and emotional resources and prevent long and short-term effects from diabetes. Diabetes self-management education (DSME) is the essential first step in becoming an effective self-manager. DSME is designed to help patients make informed decisions and evaluate the costs and benefits of those choices. In addition to DSME, patients with diabetes also need on-going self-management support (DSMS) in order to sustain improvements gained during DSME. Table 3 summarizes self-management topics (...) need DSME, it is unreasonable to believe that a one-time educational program will be adequate for a lifetime. Self-management support is defined as the on- going assistance and resources patients need in order to make self-management decisions and sustain behavioral changes. Office-based practices providing multiple interventions in which patient education was included or where the role of the nurse was enhanced reported favorable outcomes. Organizational interventions that improve diabetes self

2017 University of Michigan Health System

279. Management of Diabetes Mellitus in Primary Care

for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/quality-patient-safety/quality-resources/tools/literacy-toolkit/healthlittoolkit2-tool5.htmlVA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care April 2017 Page 20 of 160 b. Module B: Diabetes Self-Management Education VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care April 2017 Page 21 of 160 VI. Recommendations # Recommendation (...) Strength* Category† A. General Approach to T2DM Care 1. We recommend shared decision-making to enhance patient knowledge and satisfaction. Strong for Reviewed, New-added 2. We recommend that all patients with diabetes should be offered ongoing individualized diabetes self-management education via various modalities tailored to their preferences, learning needs and abilities based on available resources. Strong for Reviewed, New-replaced 3. We suggest offering one or more types of bidirectional

2017 VA/DoD Clinical Practice Guidelines

280. Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors: Behavioral Counseling

several community-based interventions to promote physical activity, including community-wide campaigns, social support interventions, school-based physical education, and environmental and policy approaches. It also recommends programs promoting healthful diet and physical activity for persons at increased risk for type 2 diabetes on the basis of strong evidence of the effectiveness of these programs in reducing the incidence of new-onset diabetes. Useful Resources The USPSTF has evaluated (...) and vegetable consumption, total daily caloric intake, salt intake, and physical activity levels. Behavioral counseling interventions led to improvements in systolic and diastolic blood pressure levels, low-density lipoprotein cholesterol (LDL-C) levels, body mass index (BMI), and waist circumference that persisted over 6 to 12 months. The USPSTF found inadequate direct evidence that behavioral counseling interventions lead to a reduction in mortality or CVD rates. Harms of Behavioral Counseling

2017 U.S. Preventive Services Task Force

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>